Related references
Note: Only part of the references are listed.Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III
Xiangyang Zu et al.
ANTIVIRAL RESEARCH (2014)
Phase III Clinical Trials Comparing the Immunogenicity and Safety of the Vero Cell-Derived Japanese Encephalitis Vaccine Encevac with Those of Mouse Brain-Derived Vaccine by Using the Beijing-1 Strain
Chiaki Miyazaki et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005-2012
Yu Liu et al.
VACCINE (2014)
A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available
Tomohiro Ishikawa et al.
VACCINE (2014)
Cellular DDX3 regulates Japanese encephalitis virus replication by interacting with viral un-translated regions
Chen Li et al.
VIROLOGY (2014)
Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model
Zixue Shi et al.
VIROLOGY JOURNAL (2014)
Flavivirus Entry Receptors: An Update
Manuel Perera-Lecoin et al.
VIRUSES-BASEL (2014)
Surveillance of Japanese Encephalitis Virus Infection in Mosquitoes in Vietnam from 2006 to 2008
Ryusei Kuwata et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
The DEAD-box RNA helicase DDX5 acts as a positive regulator of Japanese encephalitis virus replication by binding to viral 3′ UTR
Chen Li et al.
ANTIVIRAL RESEARCH (2013)
Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo
Hassan Z. A. Ishag et al.
ARCHIVES OF VIROLOGY (2013)
Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes
Elina O. Erra et al.
CLINICAL INFECTIOUS DISEASES (2013)
IXIARO((R)) updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis
Tomas Jelinek
EXPERT REVIEW OF VACCINES (2013)
Inhibition of Japanese encephalitis virus infection in vitro and in vivo by pokeweed antiviral protein
Hassan Z. A. Ishag et al.
VIRUS RESEARCH (2013)
Review of Climate, Landscape, and Viral Genetics as Drivers of the Japanese Encephalitis Virus Ecology
Guillaume Le Flohic et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Crystal Structure of the Full-Length Japanese Encephalitis Virus NS5 Reveals a Conserved Methyltransferase- Polymerase Interface
Guoliang Lu et al.
PLOS PATHOGENS (2013)
Effect of the methyltransferase domain of Japanese encephalitis virus NS5 on the polymerase activity
Qiang Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2012)
Molecular phylogenetic and evolutionary analysis of Japanese encephalitis virus in China
S. P. Chen
EPIDEMIOLOGY AND INFECTION (2012)
siRNA-mediated suppression of Japanese encephalitis virus replication in cultured cells and mice
Manu Anantpadma et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Microneedles: an emerging transdermal drug delivery system
Shital H. Bariya et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)
Crystal Structure of the Japanese Encephalitis Virus Envelope Protein
Vincent C. Luca et al.
JOURNAL OF VIROLOGY (2012)
Japanese Encephalitis Virus Enters Rat Neuroblastoma Cells via a pH-Dependent, Dynamin and Caveola-Mediated Endocytosis Pathway
Yong-Zhe Zhu et al.
JOURNAL OF VIROLOGY (2012)
Combination of N-methylisatin-ß-thiosemicarbazone derivative (SCH16) with ribavirin and mycophenolic acid potentiates the antiviral activity of SCH16 against Japanese encephalitis virus in vitro
L. Sebastian et al.
LETTERS IN APPLIED MICROBIOLOGY (2012)
Japanese encephalitis and Japanese encephalitis virus in mainland China
Yayun Zheng et al.
REVIEWS IN MEDICAL VIROLOGY (2012)
Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: A case-control study
Charung Muangchana et al.
VACCINE (2012)
Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK®V) in children
Kenji Okada et al.
VACCINE (2012)
Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated)
Akiko Kikukawa et al.
VACCINE (2012)
Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months Randomized, controlled phase 3 immunogenicity and safety trial
Emmanuel Feroldi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Unique heparan sulfate from shrimp heads exhibits a strong inhibitory effect on infections by dengue virus and Japanese encephalitis virus
Jiancheng Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Estimated global incidence of Japanese encephalitis: a systematic review
Grant L. Campbell et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2011)
FUSE Binding Protein 1 Interacts with Untranslated Regions of Japanese Encephalitis Virus RNA and Negatively Regulates Viral Replication
Hsu-Ling Chien et al.
JOURNAL OF VIROLOGY (2011)
Heterogeneous Nuclear Ribonucleoprotein A2 Participates in the Replication of Japanese Encephalitis Virus through an Interaction with Viral Proteins and RNA
Hiroshi Katoh et al.
JOURNAL OF VIROLOGY (2011)
Broad-Spectrum Antiviral Activity of RNA Interference against Four Genotypes of Japanese Encephalitis Virus Based on Single MicroRNA Polycistrons
Zhiqiang Wu et al.
PLOS ONE (2011)
Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China
Xinyu Liu et al.
VACCINE (2011)
Emergence of Japanese encephalitis virus genotype V in the Republic of Korea
Ratree Takhampunya et al.
VIROLOGY JOURNAL (2011)
Genotype V Japanese Encephalitis Virus Is Emerging
Ming-Hua Li et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Introduction of Japanese Encephalitis Virus Genotype I, India
Pradip V. Fulmali et al.
EMERGING INFECTIOUS DISEASES (2011)
Japanese Encephalitis Virus Genotype Replacement, Taiwan, 2009-2010
Yi-Ying Chen et al.
EMERGING INFECTIOUS DISEASES (2011)
Japanese Encephalitis in Travelers from Non-Endemic Countries, 1973-2008
Susan L. Hills et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Structure-based virtual screening for novel inhibitors of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase
Agnieszka Kaczor et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2010)
Combating Japanese encephalitis: Vero-cell derived inactivated vaccines and the situation in Japan
Tomohiro Ishikawa et al.
FUTURE VIROLOGY (2010)
Long-term immunity to live attenuated Japanese encephalitis chimeric virus vaccine Randomized, double-blind, five-year phase II study in healthy adults
Peter E. Nasveld et al.
HUMAN VACCINES (2010)
Molecular evolution of Japanese encephalitis virus isolates from swine in Oita, Japan during 1980-2009
Wei-Feng Tang et al.
INFECTION GENETICS AND EVOLUTION (2010)
Inhibition of Japanese encephalitis virus replication in cultured cells and mice by a peptide-conjugated morpholino oligomer
Manu Anantpadma et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Targeted Delivery of Small Interfering RNA to Human Dendritic Cells To Suppress Dengue Virus Infection and Associated Proinflammatory Cytokine Production
Sandesh Subramanya et al.
JOURNAL OF VIROLOGY (2010)
Adverse event reports following Japanese encephalitis vaccination in the United States, 1999-2009
Nicole P. Lindsey et al.
VACCINE (2010)
Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age
A. Kaltenboeck et al.
VACCINE (2010)
Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials
Joseph Torresi et al.
VACCINE (2010)
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
Bruno Guy et al.
VACCINE (2010)
Antiviral and Neuroprotective Role of Octaguanidinium Dendrimer-Conjugated Morpholino Oligomers in Japanese Encephalitis
Arshed Nazmi et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Molecular Epidemiology of Japanese Encephalitis Virus, Taiwan
Jyh-Hsiung Huang et al.
EMERGING INFECTIOUS DISEASES (2010)
Ecology and Geographical Expansion of Japanese Encephalitis Virus
Andrew F. van den Hurk et al.
ANNUAL REVIEW OF ENTOMOLOGY (2009)
Randomized, Controlled Trial of Oral Ribavirin for Japanese Encephalitis in Children in Uttar Pradesh, India
Rashmi Kumar et al.
CLINICAL INFECTIOUS DISEASES (2009)
La protein binds the predicted loop structures in the 3 ' non-coding region of Japanese encephalitis virus genome: role in virus replication
Surender Vashist et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Detection of Antibodies against Japanese Encephalitis Virus in Raccoons, Raccoon Dogs and Wild Boars in Japan
Yoshito Ohno et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2009)
Effectiveness of One Dose of SA 14-14-2 Vaccine against Japanese Encephalitis
Rashmi Kumar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study
Elisabeth Schuller et al.
VACCINE (2009)
Genome cyclization as strategy for flavivirus RNA replication
Sergio M. Villordo et al.
VIRUS RESEARCH (2009)
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) interaction with 3′ ends of Japanese encephalitis virus RNA and colocalization with the viral NS5 protein
Shang-Hua Yang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2009)
Post-vaccination encephalomyelitis: Literature review and illustrative case
William Huynh et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine
E. Tauber et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses
Young Mo Sohn et al.
VACCINE (2008)
Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study
E. Schuller et al.
VACCINE (2008)
Crystal structure of the catalytic domain of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase at a resolution of 1.8 Å
Tetsuo Yamashita et al.
VIROLOGY (2008)
Change in Japanese Encephalitis Virus Distribution, Thailand
Narong Nitatpattana et al.
EMERGING INFECTIOUS DISEASES (2008)
Safety and immunogenicity of a Vero-cell-derived,inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial
E. Tauber et al.
LANCET (2007)
Japanese encephalitis revisited
Mouhamadou Diagana et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Identification and characterization of RNA-dependent RNA polymerase activity in recombinant Japanese encephalitis virus NS5 protein
F. Yu et al.
ARCHIVES OF VIROLOGY (2007)
Detection of antibodies to Japanese encephalitis virus in the wild boars in Hiroshima prefecture, Japan
M. Hamano et al.
EPIDEMIOLOGY AND INFECTION (2007)
Transvascular delivery of small interfering RNA to the central nervous system
Priti Kumar et al.
NATURE (2007)
Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: A case-control study in Nepalese children 5 years after immunization
J. B. Tandan et al.
VACCINE (2007)
Molecular epidemiological analysis of Japanese encephalitis virus in China
Huan Yu Wang et al.
JOURNAL OF GENERAL VIROLOGY (2007)
A single siRNA suppresses fatal encephalitis induced by two different flaviviruses
Priti Kumar et al.
PLOS MEDICINE (2006)
Polypyrimidine tract-binding protein interacts with the 3′ stem-loop region of Japanese encephalitis virus negative-strand RNA
SM Kim et al.
VIRUS RESEARCH (2006)
High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery
F Puig-Basagoiti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004
J Hombach et al.
VACCINE (2005)
Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study
H Ohrr et al.
LANCET (2005)
Inhibitory effect of RNAi on Japanese encephalitis virus replication in vitro and in vivo
M Murakami et al.
MICROBIOLOGY AND IMMUNOLOGY (2005)
Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine
DWC Beasley et al.
VACCINE (2004)
Isolation of capsid protein dimers from the tick-borne encephalitis flavivirus and in vitro assembly of capsid-like particles
S Kiermayr et al.
JOURNAL OF VIROLOGY (2004)
Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from Southeast Asia to East Asia
PT Nga et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): Phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen
TP Monath et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine
M Nawa et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial
T Solomon et al.
LANCET (2003)
Origin and evolution of Japanese encephalitis virus in southeast Asia
T Solomon et al.
JOURNAL OF VIROLOGY (2003)
Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses
JM Crance et al.
ANTIVIRAL RESEARCH (2003)
Visualization of membrane protein domains by cryo-electron microscopy of dengue virus
W Zhang et al.
NATURE STRUCTURAL BIOLOGY (2003)
Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion
RJ Kuhn et al.
CELL (2002)
Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study
MB Bista et al.
LANCET (2001)
Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States
H Takahashi et al.
VACCINE (2000)
Mov34 protein from mouse brain interacts with the 3′ noncoding region of Japanese encephalitis virus
M Ta et al.
JOURNAL OF VIROLOGY (2000)
Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains
I Kurane et al.
VACCINE (2000)
Japanese encephalitis
T Solomon et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
Identification and characterization of the RNA helicase activity of Japanese encephalitis virus NS3 protein
A Utama et al.
FEBS LETTERS (2000)
Share Paper
